"The company does not disclose business figures. But one thing is clear: Aurora operates in a growing market. About 20 to 30,000 patients in Germany are currently receiving cannabis as medicine, primarily as a pain reliever drug. There could be ten times as many in the future if you compare Germany with countries in which cannabis has been approved for a long time. Aside from that:"